Clinically™ - Powered by EmpiRx Health’s Post

This morning, The New York Times published a devastating exposé on the traditional PBM industry. The article shines a blazing spotlight on the traditional PBM practices that prioritize rebate-driven drug volume to maximize profits. Practices like these are hurting plan sponsors, members/patients, community pharmacies, and many other stakeholders. Clearly illustrating why a clinically-driven, customer-first pharmacy care alternative is more vital than ever, below is how the NY Times described the self-dealing practices of the Big 3 PBMs: “The job of the P.B.M.s is to reduce drug costs. Instead, they frequently do the opposite. They steer patients toward pricier drugs, charge steep markups on what would otherwise be inexpensive medicines and extract billions of dollars in hidden fees, a New York Times investigation found.” Read the full article here. https://lnkd.in/eU6p-vFb EmpiRx Health's clinically-driven pharmacy care approach is by far the best alternative to the legacy PBMs, who prioritize their own profits at the expense of their customers. Want to learn more about why plan sponsors and their advisors and consultants are increasingly choosing EmpiRx Health for their pharmacy benefits care? Contact us today! https://lnkd.in/eeiGZpxM #PBM #Healthcare #NewYorkTimes

This morning, The New York Times published a devastating exposé on the traditional PBM industry. The article shines a blazing spotlight on the traditional PBM practices that prioritize rebate-driven drug volume to maximize profits. Practices like these are hurting plan sponsors, members/patients, community pharmacies, and many other stakeholders.   Clearly illustrating why a clinically-driven, customer-first pharmacy care alternative is more vital than ever, below is how the NY Times described the self-dealing practices of the Big 3 PBMs:    “The job of the P.B.M.s is to reduce drug costs. Instead, they frequently do the opposite. They steer patients toward pricier drugs, charge steep markups on what would otherwise be inexpensive medicines and extract billions of dollars in hidden fees, a New York Times investigation found.”   Read the full article here. https://lnkd.in/eU6p-vFb   EmpiRx Health’s clinically-driven pharmacy care approach is by far the best alternative to the legacy PBMs, who prioritize their own profits at the expense of their customers. Want to learn more about why plan sponsors and their advisors and consultants are increasingly choosing EmpiRx Health for their pharmacy benefits care? Contact us today! https://lnkd.in/eeiGZpxM #PBM #Healthcare #NewYorkTimes

This morning, The New York Times published a devastating exposé on the traditional PBM industry. The article shines a blazing spotlight on the traditional PBM practices that prioritize rebate-driven drug volume to maximize profits. Practices like these are hurting plan sponsors, members/patients, community pharmacies, and many other stakeholders.   Clearly illustrating why a clinically-driven, customer-first pharmacy care alternative is more vital than ever, below is how the NY Times described the self-dealing practices of the Big 3 PBMs:    “The job of the P.B.M.s is to reduce drug costs. Instead, they frequently do the opposite. They steer patients toward pricier drugs, charge steep markups on what would otherwise be inexpensive medicines and extract billions of dollars in hidden fees, a New York Times investigation found.”   Read the full article here. https://lnkd.in/eU6p-vFb   EmpiRx Health’s clinically-driven pharmacy care approach is by far the best alternative to the legacy PBMs, who prioritize their own profits at the expense of their customers. Want to learn more about why plan sponsors and their advisors and consultants are increasingly choosing EmpiRx Health for their pharmacy benefits care? Contact us today! https://lnkd.in/eeiGZpxM #PBM #Healthcare #NewYorkTimes

This morning, The New York Times published a devastating exposé on the traditional PBM industry. The article shines a blazing spotlight on the traditional PBM practices that prioritize rebate-driven drug volume to maximize profits. Practices like these are hurting plan sponsors, members/patients, community pharmacies, and many other stakeholders.   Clearly illustrating why a clinically-driven, customer-first pharmacy care alternative is more vital than ever, below is how the NY Times described the self-dealing practices of the Big 3 PBMs:    “The job of the P.B.M.s is to reduce drug costs. Instead, they frequently do the opposite. They steer patients toward pricier drugs, charge steep markups on what would otherwise be inexpensive medicines and extract billions of dollars in hidden fees, a New York Times investigation found.”   Read the full article here. https://lnkd.in/eU6p-vFb   EmpiRx Health’s clinically-driven pharmacy care approach is by far the best alternative to the legacy PBMs, who prioritize their own profits at the expense of their customers. Want to learn more about why plan sponsors and their advisors and consultants are increasingly choosing EmpiRx Health for their pharmacy benefits care? Contact us today! https://lnkd.in/eeiGZpxM #PBM #Healthcare #NewYorkTimes